Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Net Income (2016 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Net Income for 6 consecutive years, with -$3.1 million as the latest value for Q4 2021.

  • Quarterly Net Income fell 37.94% to -$3.1 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$11.2 million through Dec 2021, up 4.22% year-over-year, with the annual reading at -$7.0 million for FY2025, 38.93% up from the prior year.
  • Net Income for Q4 2021 was -$3.1 million at ENDRA Life Sciences, down from -$2.7 million in the prior quarter.
  • The five-year high for Net Income was -$741623.0 in Q1 2017, with the low at -$4.8 million in Q4 2019.
  • Average Net Income over 5 years is -$2.6 million, with a median of -$2.7 million recorded in 2019.
  • The sharpest move saw Net Income tumbled 280.96% in 2018, then skyrocketed 53.2% in 2020.
  • Over 5 years, Net Income stood at -$2.3 million in 2017, then dropped by 3.09% to -$2.4 million in 2018, then tumbled by 103.3% to -$4.8 million in 2019, then surged by 53.2% to -$2.3 million in 2020, then plummeted by 37.94% to -$3.1 million in 2021.
  • According to Business Quant data, Net Income over the past three periods came in at -$3.1 million, -$2.7 million, and -$3.2 million for Q4 2021, Q3 2021, and Q2 2021 respectively.